AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 41 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $122,000 | +35.6% | 41,525 | +22.0% | 0.00% | 0.0% |
| Q2 2018 | $90,000 | -79.7% | 34,050 | +8.2% | 0.00% | -75.0% |
| Q1 2018 | $443,000 | +44.8% | 31,472 | +21.0% | 0.00% | +100.0% |
| Q4 2017 | $306,000 | -6.7% | 26,001 | +12.5% | 0.00% | 0.0% |
| Q3 2017 | $328,000 | +10.4% | 23,110 | +9.6% | 0.00% | 0.0% |
| Q2 2017 | $297,000 | -11.6% | 21,090 | +4.7% | 0.00% | 0.0% |
| Q1 2017 | $336,000 | -9.7% | 20,151 | -10.5% | 0.00% | -33.3% |
| Q4 2016 | $372,000 | +117.5% | 22,508 | +16.3% | 0.00% | +50.0% |
| Q1 2016 | $171,000 | -39.6% | 19,356 | -14.6% | 0.00% | -33.3% |
| Q4 2015 | $283,000 | – | 22,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
| EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
| EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
| Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
| DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
| UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
| Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
| DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
| DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |